Pure Global

Nucleus Diagnosys LLP - Medical Device License Holder

Nucleus Diagnosys LLP is a medical device license holder with 249 registered products in the India CDSCO database through Pure Global AI's free platform. The company produces devices under 2 brands including TRA, HIV 1&2. Products span 2 device classes: Class C, Class D.

This page provides comprehensive license holder intelligence including complete product portfolio showing all 249 registered devices, brand analysis across 2 different brands, and 20 unique product types. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze portfolios, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
249 Products
2 Brands
Nucleus Diagnosys LLP
License Holder in India
249
Total Products
2
Brands
2
Device Classes
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Brand Portfolio (2)
Products organized by brand name

TRA

3 products
Diagnostics test reagent/ kits for Troponin I, Diagnostics test reagent/ kits for Antistreptolysin O Control, D Dimer

HIV 1&2

2 products
Covid-19 Rapid Antigen Test-COVID-19 Antigen Test is a rapid and convenient immunochromatographic assay for the qualitative detection of COVID-19 antigen from nasopharyngeal/nasal swab obtained from patient with signs and symptoms of respiratory infection. This test is for administration by healthcare workers and labs only, as an aid to early diagnosis of SARS-CoV-2 infection in patient with clinical symptoms of SARS-CoV-2 infection. It provides only an initial screening test result. This product is strictly for medical professional use only and not intended for personal use. The result of this test should not be the sole basis for the diagnosis and the test results should be confirmed by Real-Time Reverse Transcriptase , Diagnostics test reagent/Kit for Hepatitis B Virus Surface Antigen

Products (showing 20 of 249)